Sector: Healthcare | Industry: Managed Health Care |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 7700 Forsyth Blvd ST. LOUIS MO 63105-1807 |
Tel: | N/A |
Website: | https://www.centene.com |
IR: | See website |
Key People | ||
Kenneth J. Fasola President | Shannon T. Susko Senior Vice President, Chief Communications Officer | Sarah M. London Chief Executive Officer, Director |
Andrew L. Asher Chief Financial Officer, Executive Vice President | Michael A. Carson President, Chief Executive Officer | Susan Smith Chief Operating Officer |
Tanya Mcnally Senior Vice President and Chief People Officer | Christopher A. Koster Executive Vice President, General Counsel, Company Secretary | Mark J. Brooks Executive Vice President | Katie N. Casso Senior Vice President, Corporate Controller and Chief Accounting Officer |
Business Overview |
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases. |
Financial Overview |
For the fiscal year ended 31 December 2023, Centene Corp revenues increased 7% to $154B. Net income increased from $1.2B to $2.7B. Revenues reflect Medicaid segment increase of 8% to $100.76B, General & Administration Ratio, Total increase of 5% to 9%. Net income benefited from Acquisition related expenses decrease of 66% to $69M (expense). Basic Earnings per Share excluding Extraordinary Items increased from $2.09 to $4.97. |
Employees: | 67,700 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $38,605M as of Dec 31, 2023 |
Annual revenue (TTM): | $153,999M as of Dec 31, 2023 |
EBITDA (TTM): | $4,725M as of Dec 31, 2023 |
Net annual income (TTM): | $2,702M as of Dec 31, 2023 |
Free cash flow (TTM): | $7,204M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 534,905,828 as of Mar 15, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |